Calprotectin in spondyloarthritis: A systematic review and meta-analysis
•Serum and fecal calprotectin were increased in SpA patients.•Level of serum or fecal calprotectin was associated with CRP, ESR, BASDAI and BASFI.•Serum and fecal calprotectin could act as biomarkers for SpA. There is still an unmet need for a simple and reliable biomarker for diagnosis and disease...
Gespeichert in:
Veröffentlicht in: | International immunopharmacology 2020-11, Vol.88, p.106948-106948, Article 106948 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!